Oncolytics Biotech (ONCY) Stock Chart & Stock Price History $1.28 +0.03 (+2.40%) (As of 10/17/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Oncolytics Biotech Stock Price Performance5 Day Performance+2.40%1 Month Performance+33.51%3 Month Performance+20.77%6 Month Performance+23.08%Year-To-Date Performance-5.19%1 Year Performance-29.28% Receive ONCY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oncolytics Biotech and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Click here to watch it now. ONCY Stock Chart for Thursday, October, 17, 2024 ONCY Chart by TradingView Oncolytics Biotech Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/17/2024$1.25$1.28+2.40%$1.30$1.25450,424 shs$97.68 million10/16/2024$1.24$1.25+0.81%$1.27$1.21371,860 shs$95.39 million10/15/2024$1.15$1.24+7.83%$1.30$1.13907,347 shs$94.63 million10/14/2024$1.25$1.15-8.00%$1.26$1.121.15 million shs$87.76 million10/11/2024$1.24$1.25+0.81%$1.27$1.21536,502 shs$96.34 million10/10/2024$1.31$1.24-5.34%$1.33$1.16769,648 shs$94.63 million Get the Latest News and Ratings for ONCY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oncolytics Biotech and its competitors with MarketBeat's FREE daily newsletter. 10/09/2024$1.27$1.31+3.15%$1.35$1.20732,189 shs$99.97 million10/08/2024$1.40$1.27-9.29%$1.49$1.212.60 million shs$97.84 million10/07/2024$1.10$1.40+27.27%$1.53$1.164.34 million shs$107.86 million10/04/2024$0.93$1.10+18.22%$1.14$0.951.81 million shs$84.74 million10/03/2024$0.85$0.93+9.09%$0.94$0.85328,524 shs$71.69 million10/02/2024$0.86$0.85-0.93%$0.89$0.85267,088 shs$65.09 million10/01/2024$0.87$0.86-1.15%$0.89$0.84273,572 shs$66.33 million09/30/2024$0.89$0.87-2.34%$0.90$0.87280,101 shs$67.10 million09/27/2024$0.90$0.89-0.64%$0.90$0.88203,138 shs$68.06 million09/26/2024$0.90$0.90-0.23%$0.92$0.89139,419 shs$69.15 million09/25/2024$0.90$0.90-0.03%$0.93$0.89157,931 shs$69.31 million09/24/2024$0.91$0.90-1.03%$0.93$0.89440,692 shs$68.68 million09/23/2024$0.92$0.91-1.57%$0.94$0.90226,532 shs$69.40 million09/20/2024$0.95$0.92-2.75%$0.97$0.92249,472 shs$70.50 million09/19/2024$0.93$0.95+2.15%$0.97$0.92229,426 shs$72.50 million09/18/2024$0.96$0.93-2.99%$0.96$0.93155,370 shs$70.97 million09/17/2024$0.95$0.96+0.99%$0.99$0.92353,842 shs$73.82 million09/16/2024$0.96$0.95-0.70%$0.97$0.9380,096 shs$72.44 million09/13/2024$0.96$0.96-0.28%$0.97$0.93141,951 shs$72.95 million09/12/2024$0.95$0.96+1.45%$0.98$0.9396,137 shs$73.82 million09/11/2024$0.98$0.95-3.08%$0.97$0.94153,743 shs$72.77 million09/10/2024$0.93$0.98+4.84%$0.98$0.93191,364 shs$75.08 million09/09/2024$0.96$0.93-2.92%$0.97$0.92139,457 shs$71.61 million09/06/2024$0.99$0.96-3.04%$1.00$0.92151,803 shs$73.77 million09/05/2024$1.01$0.99-2.18%$1.02$0.97110,334 shs$76.08 million09/04/2024$0.95$1.01+6.29%$1.01$0.94162,820 shs$77.07 million09/03/2024$0.96$0.95-0.92%$0.98$0.9389,038 shs$73.17 million09/02/2024$0.96$0.96$0.99$0.90171,300 shs$73.84 million08/30/2024$0.95$0.96+0.66%$0.99$0.90171,313 shs$73.18 million08/29/2024$0.96$0.95-0.69%$0.97$0.9592,900 shs$72.70 million08/28/2024$0.97$0.96-0.82%$0.97$0.95107,379 shs$73.21 million08/27/2024$0.97$0.97-0.18%$0.97$0.95120,161 shs$73.81 million08/26/2024$0.99$0.97-2.13%$0.99$0.96118,780 shs$73.94 million08/23/2024$0.95$0.99+4.21%$0.99$0.95239,540 shs$76.09 millionEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New Prediction (Ad)Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER…08/22/2024$0.95$0.95+0.01%$0.95$0.9453,424 shs$72.50 million08/21/2024$0.95$0.95+0.01%$0.97$0.93148,522 shs$72.49 million08/20/2024$0.97$0.95-2.06%$0.98$0.94145,037 shs$73.00 million08/19/2024$0.96$0.97+1.24%$1.00$0.94153,251 shs$74.54 million08/16/2024$0.97$0.96-1.26%$0.99$0.93263,390 shs$73.62 million08/15/2024$0.98$0.97-1.01%$0.99$0.96121,642 shs$74.56 million08/14/2024$0.91$0.98+7.66%$0.99$0.93386,255 shs$74.79 million08/13/2024$0.95$0.91-4.06%$0.95$0.85645,941 shs$69.47 million08/12/2024$0.97$0.95-2.21%$1.01$0.93302,029 shs$72.40 million08/09/2024$0.99$0.98-0.58%$0.99$0.97109,478 shs$74.79 million08/08/2024$1.00$0.99-0.95%$0.99$0.96148,628 shs$75.22 million08/07/2024$1.01$1.00-1.47%$1.03$0.98148,385 shs$76.49 million08/06/2024$0.98$1.01+2.72%$1.02$0.98150,222 shs$77.63 million08/05/2024$1.02$0.98-3.60%$1.02$0.95567,868 shs$75.58 million08/02/2024$1.03$1.02-0.97%$1.05$1.01418,919 shs$78.40 million08/01/2024$1.04$1.03-0.96%$1.06$1.02153,553 shs$79.17 million07/31/2024$1.05$1.04-0.95%$1.06$1.04149,075 shs$79.93 million07/30/2024$1.05$1.05$1.06$1.0383,663 shs$80.13 million07/29/2024$1.04$1.05+0.96%$1.07$1.03150,888 shs$80.13 million07/26/2024$1.04$1.04$1.08$1.0394,830 shs$79.36 million07/25/2024$1.03$1.04+0.97%$1.05$1.0273,626 shs$79.36 million07/24/2024$1.02$1.03+0.98%$1.05$1.0185,468 shs$78.60 million07/23/2024$1.02$1.02$1.04$1.01102,208 shs$77.84 million07/22/2024$1.03$1.02-0.97%$1.04$1.02155,684 shs$77.84 million07/19/2024$1.03$1.03$1.05$1.0280,901 shs$78.60 million07/18/2024$1.06$1.03-2.82%$1.05$1.03159,057 shs$78.60 million07/17/2024$1.07$1.06-0.94%$1.08$1.02173,410 shs$80.88 million07/16/2024$1.08$1.07-0.93%$1.10$1.07122,927 shs$81.65 million Related Companies: Orgenesis Stock Chart Enlivex Therapeutics Stock Chart Verve Therapeutics Stock Chart G1 Therapeutics Stock Chart Lakeshore Biopharma Stock Chart Corvus Pharmaceuticals Stock Chart Voyager Therapeutics Stock Chart Canopy Growth Stock Chart C4 Therapeutics Stock Chart Zevra Therapeutics Stock Chart Receive ONCY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oncolytics Biotech and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ONCY) was last updated on 10/17/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredRetire off just one stock ticker?ONE AI Stock is All You Need... There are over 6,000 stocks listed in the market right now. They will NOT m...Behind the Markets | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredAdd $2T of Potential Magic to Your PortfolioRevolutionizing a whole $2T entertainment and licensing industry might sound like the stuff of fairytales. But...Elf Labs | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMassive trading opportunity begins by October 21 October 21 could spark a mania among “next-generation” AI stocks. That’s the newest prediction from a Wall Str...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncolytics Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncolytics Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.